Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Ferone

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Tumori|February 10, 2011
Somatostatin and dopamine receptorsDiego Ferone
Thoracic Surgery Clinics|July 29, 2014
Ectopic Cushing and other paraneoplastic syndromes in thoracic neuroendocrine tumorsDiego Ferone, Manuela Albertelli
Neuroendocrinology|January 18, 2012
Diffuse endocrine system, neuroendocrine tumors and immunity: what's new?Pietro Ameri, Diego Ferone
Acta Diabetologica|March 27, 2009
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalitiesEugenia Resmini, Francesco Minuto, Annamaria Colao, et al.
Endocrine Reviews|February 11, 2004
Systemic complications of acromegaly: epidemiology, pathogenesis, and managementAnnamaria Colao, Diego Ferone, Paolo Marzullo, et al.
Expert Opinion on Pharmacotherapy|September 29, 2020
Use of octreotide long acting repeatable (LAR) as second-line therapy in advanced neuroendocrine tumors in different clinical settings: an Italian Delphi surveyMassimo Falconi, Nicola Fazio, Diego Ferone, et al.
Clinical Endocrinology|June 20, 2002
(99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapyAnnamaria Colao, Diego Ferone, Gaetano Lombardi, et al.
Frontiers of Hormone Research|August 26, 2015
Hormone and Receptor Candidates for Target and Biotherapy of Neuroendocrine TumorsLeo J Hofland, Timon Vandamme, Manuela Albertelli, et al.
Endocrine|January 14, 2014
Managing Cushing's disease: the state of the artAnnamaria Colao, Marco Boscaro, Diego Ferone, et al.
Current Oncology Reports|May 3, 2021
Advanced Pancreatic Neuroendocrine Neoplasms: Which Systemic Treatment Should I Start With?Victor Rodriguez-Freixinos, Alia Thawer, Jaume Capdevila, et al.
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Tumori|February 10, 2011
Somatostatin and dopamine receptorsDiego Ferone
Thoracic Surgery Clinics|July 29, 2014
Ectopic Cushing and other paraneoplastic syndromes in thoracic neuroendocrine tumorsDiego Ferone, Manuela Albertelli
Neuroendocrinology|January 18, 2012
Diffuse endocrine system, neuroendocrine tumors and immunity: what's new?Pietro Ameri, Diego Ferone
Acta Diabetologica|March 27, 2009
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalitiesEugenia Resmini, Francesco Minuto, Annamaria Colao, et al.
Endocrine Reviews|February 11, 2004
Systemic complications of acromegaly: epidemiology, pathogenesis, and managementAnnamaria Colao, Diego Ferone, Paolo Marzullo, et al.
Expert Opinion on Pharmacotherapy|September 29, 2020
Use of octreotide long acting repeatable (LAR) as second-line therapy in advanced neuroendocrine tumors in different clinical settings: an Italian Delphi surveyMassimo Falconi, Nicola Fazio, Diego Ferone, et al.
Clinical Endocrinology|June 20, 2002
(99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapyAnnamaria Colao, Diego Ferone, Gaetano Lombardi, et al.
Frontiers of Hormone Research|August 26, 2015
Hormone and Receptor Candidates for Target and Biotherapy of Neuroendocrine TumorsLeo J Hofland, Timon Vandamme, Manuela Albertelli, et al.
Endocrine|January 14, 2014
Managing Cushing's disease: the state of the artAnnamaria Colao, Marco Boscaro, Diego Ferone, et al.
Current Oncology Reports|May 3, 2021
Advanced Pancreatic Neuroendocrine Neoplasms: Which Systemic Treatment Should I Start With?Victor Rodriguez-Freixinos, Alia Thawer, Jaume Capdevila, et al.
Pageof 18